[{"address1": "700 Quince Orchard Road", "city": "Gaithersburg", "state": "MD", "zip": "20878", "country": "United States", "phone": "240 268 2000", "website": "https://www.novavax.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.", "fullTimeEmployees": 952, "companyOfficers": [{"maxAge": 1, "name": "Mr. John Charles Jacobs M.B.A.", "age": 58, "title": "President, CEO & Director", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 1550611, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James Patrick Kelly C.F.A.", "age": 59, "title": "Executive VP, CFO & Treasurer", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 880849, "exercisedValue": 0, "unexercisedValue": 19825}, {"maxAge": 1, "name": "Mr. Mark J. Casey Esq.", "age": 62, "title": "Executive VP, Chief Legal Officer & Corporate Secretary", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 997654, "exercisedValue": 0, "unexercisedValue": 89347}, {"maxAge": 1, "name": "Ms. Elaine  O'Hara", "age": 57, "title": "Executive VP & Chief Strategy Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 991316, "exercisedValue": 0, "unexercisedValue": 35053}, {"maxAge": 1, "name": "Mr. Richard P. Crowley", "age": 68, "title": "Executive VP & COO", "yearBorn": 1957, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Luis  Sanay C.F.A.", "title": "Vice President of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Troy  Morgan Esq., J.D.", "age": 54, "title": "Senior VP, Deputy General Counsel & Chief Compliance Officer", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Erika S. Trahan", "title": "Associate Director of Investor & Public Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ian J. Watkins", "age": 62, "title": "Executive VP & Chief Human Resources Officer", "yearBorn": 1963, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Silvia  Taylor M.B.A.", "title": "Executive VP, Chief Corporate Affairs Officer & Head of Novavax Sweden", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 5, "compensationRisk": 6, "shareHolderRightsRisk": 5, "overallRisk": 5, "governanceEpochDate": 1768176000, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://www.novavax.com/go.cfm?do=Stock.GetQuote", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 9.75, "open": 9.69, "dayLow": 9.15, "dayHigh": 9.7, "regularMarketPreviousClose": 9.75, "regularMarketOpen": 9.69, "regularMarketDayLow": 9.15, "regularMarketDayHigh": 9.7, "payoutRatio": 0.0, "beta": 2.371, "trailingPE": 4.562189, "forwardPE": -25.264492, "volume": 7571815, "regularMarketVolume": 7571815, "averageVolume": 4402062, "averageVolume10days": 8206780, "averageDailyVolume10Day": 8206780, "bid": 9.15, "ask": 9.21, "bidSize": 25, "askSize": 16, "marketCap": 1490115712, "fiftyTwoWeekLow": 5.01, "fiftyTwoWeekHigh": 10.64, "allTimeHigh": 331.68, "allTimeLow": 3.53, "priceToSalesTrailing12Months": 1.3996283, "fiftyDayAverage": 7.1582, "twoHundredDayAverage": 7.41105, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 978361792, "profitMargins": 0.32099, "floatShares": 133743173, "sharesOutstanding": 162498995, "sharesShort": 54721714, "sharesShortPriorMonth": 51861435, "sharesShortPreviousMonthDate": 1764288000, "dateShortInterest": 1767139200, "sharesPercentSharesOut": 0.3368, "heldPercentInsiders": 0.087510005, "heldPercentInstitutions": 0.62419, "shortRatio": 17.27, "shortPercentOfFloat": 0.338, "impliedSharesOutstanding": 162498995, "bookValue": -0.964, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": 341744992, "trailingEps": 2.01, "forwardEps": -0.36296, "lastSplitFactor": "1:20", "lastSplitDate": 1557446400, "enterpriseToRevenue": 0.919, "enterpriseToEbitda": 2.165, "52WeekChange": -0.016094446, "SandP52WeekChange": 0.15024745, "quoteType": "EQUITY", "currentPrice": 9.17, "targetHighPrice": 25.0, "targetLowPrice": 6.0, "targetMeanPrice": 12.88889, "targetMedianPrice": 11.0, "recommendationMean": 2.33333, "recommendationKey": "buy", "numberOfAnalystOpinions": 9, "totalCash": 762894016, "totalCashPerShare": 4.695, "ebitda": 451828000, "totalDebt": 251140000, "quickRatio": 1.854, "currentRatio": 2.267, "totalRevenue": 1064651008, "revenuePerShare": 6.595, "returnOnAssets": 0.18014, "grossProfits": 632619008, "freeCashflow": -455231136, "operatingCashflow": -378323008, "revenueGrowth": -0.166, "grossMargins": 0.59419996, "ebitdaMargins": 0.42439, "operatingMargins": -1.12684, "financialCurrency": "USD", "symbol": "NVAX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1769216372, "regularMarketTime": 1769202000, "shortName": "Novavax, Inc.", "longName": "Novavax, Inc.", "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.3 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 818173800000, "postMarketChangePercent": 0.76335543, "postMarketPrice": 9.24, "postMarketChange": 0.069999695, "regularMarketChange": -0.58, "regularMarketDayRange": "9.15 - 9.7", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 4402062, "fiftyTwoWeekLowChange": 4.16, "fiftyTwoWeekLowChangePercent": 0.83033925, "fiftyTwoWeekRange": "5.01 - 10.64", "fiftyTwoWeekHighChange": -1.4700003, "fiftyTwoWeekHighChangePercent": -0.13815792, "fiftyTwoWeekChangePercent": -1.6094446, "dividendDate": 1557446400, "earningsTimestamp": 1762435800, "earningsTimestampStart": 1762435800, "earningsTimestampEnd": 1762435800, "earningsCallTimestampStart": 1762435800, "earningsCallTimestampEnd": 1762435800, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": 2.01, "epsForward": -0.36296, "epsCurrentYear": 2.03427, "priceEpsCurrentYear": 4.5077596, "fiftyDayAverageChange": 2.0118003, "fiftyDayAverageChangePercent": 0.28104836, "twoHundredDayAverageChange": 1.7589502, "twoHundredDayAverageChangePercent": 0.23734157, "priceToBook": -9.512448, "exchange": "NMS", "messageBoardId": "finmb_350381", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -5.94872, "regularMarketPrice": 9.17, "marketState": "CLOSED", "displayName": "Novavax", "trailingPegRatio": null, "__fetch_time": "2026-01-24"}]